Antisense-based therapy salanersen (BIIB115/ION306) is a possible follow-up to Biogen's big-selling Spinraza (nusinersen) therapy for SMA, which has come under pressure from increased competition in ...

Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

Testosterone therapy did not improve walking distance in older women recovering from hip fracture compared to exercise alone, ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades from the South African Medical Research Council for their groundbreaking ...

Hibiscus, ginger, garlic, cinnamon, and other herbs may help lower blood pressure naturally. Practical tips can help you add ...

The non-alcoholic steatohepatitis (NASH) clinical trials market is estimated to generate a market size of USD 2.96 billion in ...

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...

Patel is closing in on his 20,000 tele-robotic-assisted surgeries, but this is one he will never forget. His patient on June 14 wasn’t in the same room as him, not even the same country. The man Patel ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III .